Previous Article | Next Article ![]()
Applied and Environmental Microbiology, January 2006, p. 327-333, Vol. 72, No. 1
0099-2240/06/$08.00+0 doi:10.1128/AEM.72.1.327-333.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
and
W. G. Haldenwang
Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900
Received 14 July 2005/ Accepted 19 September 2005
|
|
|---|
A- or
B-dependent promoters. Both plasmids also contain a transposable element (TnYLB-1) consisting of a Kanr cassette bracketed by the Himar1-recognized inverse terminal repeats, as well as the temperature-sensitive replicon and Ermr gene of pE194ts. TnYLB-1 transposes into the B. subtilis chromosome with high frequency (102) from either plasmid. Southern hybridization analyses of 15 transposants and sequence analyses of the insertion sites of 10 of these are consistent with random transposition, requiring only a "TA" dinucleotide as the essential target in the recipient DNA. Two hundred transposants screened for sporulation proficiency and auxotrophy yielded five Spo clones, three with insertions in known sporulation genes (kinA, spoVT, and yqfD) and two in genes (ybaN and yubB) with unknown functions. Two auxotrophic mutants were identified among the 200 transposants, one with an insertion in lysA and another in a gene (yjzB) whose function is unknown. |
|
|---|
The mariner transposable element Himar1, originally isolated from the horn fly Haematobia irritans (23), does not appear to have the limitations found in Tn917 or Tn10. When coupled to appropriate expression elements, mariner transposons have been shown to insert randomly into the chromosomes of a number of bacterial species (4, 11, 17, 21, 24, 26, 34, 38). The Himar1 transposase requires no obvious host factors to catalyze transposition, which occurs by a "cut-and-paste" reaction into the dinucleotide target "TA" (18). Given the positive attributes of the mariner system we undertook to adapt a mariner-based transposon for use in B. subtilis, using vectors and regulatory elements that might allow its eventual use in a number of gram-positive bacterial species.
|
|
|---|
and B. subtilis strain PY22 were cultured in Luria-Bertani (LB) medium (25) supplemented when necessary with the appropriate antibiotics (E. coli: ampicillin at 100 µg/ml, kanamycin [Kan] at 25 µg/ml, and erythromycin at 100 µg/ml; B. subtilis: kanamycin at 5 µg/ml and erythromycin at 1 µg/ml). Solid media contained 1.5% agar. Sporulation-deficient B. subtilis mutants were detected as colonies unable to produce brown pigment on Difco sporulation medium (DSM) (27) with kanamycin (5 µg/ml). Auxotrophic mutants were detected on minimal medium (29) supplemented with tryptophan (10 µg/ml) and kanamycin (5 µg/ml).
General molecular biology techniques.
Plasmids were isolated using the Wizard Plus SV Minipreps kit (Promega, Madison, WI). Restriction enzymes (New England Biolabs, Beverly, MA), alkaline phosphatase (Roche, Indianapolis, IN), and T4 DNA ligase (New England Biolabs, Beverly, MA) were used according to the manufacturers instructions. PCRs were performed using puRe Ready-To-Go PCR beads (Amersham Biosciences, Piscataway, NJ), 5 µg of DNA template, and 20 pmol of the appropriate primers (see Table 2). When necessary, PCR products were purified using the QIAquick PCR purification kit (QIAGEN, Valencia, CA). E. coli strains were transformed by electroporation with a Gene Pulser apparatus (Bio-Rad Laboratories, Hercules, CA) as recommended by the manufacturer. Transformation of competent B. subtilis cells was carried out by the method of Yasbin et al. (36). Chromosomal DNA from B. subtilis strains was purified as previously described (13). Southern blot analyses were performed using a DIG High Prime DNA labeling and detection starter kit (Roche, Indianapolis, IN).
|
View this table: [in a new window] |
TABLE 2. DNA sequence analysis of B. subtilis insertional mutants obtained by TnYLB-1 transposition from pMarB
|
Mapping of transposon insertion sites.
Five micrograms of transposant genomic DNA was digested with TaqI and then circularized in a ligation reaction using the "Rapid Ligation" kit (Roche, Indianapolis, IN) at a DNA concentration of 5 ng/µl. Ligation products were phenol extracted, ethanol precipitated, and resuspended in Tris-EDTA (TE) buffer at 10 ng/µl. Inverse-PCR (IPCR) was performed on 100 ng of ligated DNA with the puReTaq Ready-To-Go PCR beads (Amersham Biosciences, Piscataway, NJ) using the primers oIPCR1 and oIPCR2, which face outward from the transposon sequence (Table 1). IPCR products were purified using the QIAquick PCR purification kit (QIAGEN, Valencia, CA) and sequenced using the primer oIPCR3 (Table 1).
|
View this table: [in a new window] |
TABLE 1. Oligonucleotides used in this study
|
|
|
|---|
To construct a mariner-based transposon system for B. subtilis, the upstream and downstream ITRs of Himar1-mariner were amplified on a common DNA fragment from pMMOrf (19). A single oligonucleotide primer (oITR) (Table 1) that incorporated a PstI restriction endonuclease target sequence at its 5' end was used. This generated unique PstI recognition sites at both ends of the amplified DNA. The amplified fragment was cloned into the PstI site of pUC19 (35), forming pITR. A Kanr cassette, active in gram-positive bacteria, was cut from the streptococcal plasmid pUH1 (30) as a ClaI piece which, after being made "blunt" by Klenow DNA polymerase, was ligated into a SmaI site present between the two ITRs in pITR. The resulting plasmid (pTn1) carries TnYLB-1 (Kanr cassette flanked by the Himar1 recognition sequence). Next, a temperature-sensitive origin of replication and an erythromycin resistance cassette were amplified from the staphylococcal plasmid pE194ts (14) using oligonucleotides (oOEFwd and oOERev) (Table 1) that add EcoRI restriction sites to the fragment ends. This fragment was cloned into pTn1, forming pMarC (Fig. 1), a plasmid capable of replication in B. subtilis at 30°C but not 50°C and conferring both Ermr and Kanr on B. subtilis strains that carry it. To provide a source of Himar1 transposase, a hyperactive allele of the Himar1 gene (C9 mutant) was amplified from pBAD24 (19) using oligonucleotides oTNP1 and -2 (Table 1). The upstream oligonucleotide included a B. subtilis ribosomal binding sequence (31) placed 8 nucleotides upstream of the initiation codon of Himar1. Both oligonucleotides also included a SalI recognition site. The PCR product, cleaved with SalI, was cloned into the SalI site of pKA-16. pKA-16 is pUK19 (16) with a 370-bp EcoRI/BamHI PCR fragment encoding the PA promoter of the sigB operon (33). After verifying that Himar1 was in the correct orientation for expression from PA, the PA-Himar1 portion of the plasmid was amplified using oligonucleotides oAtnpFwd and -Rev (Table 1) and cloned as a KpnI fragment into pMarC to form pMarA (Fig. 1).
![]() View larger version (19K): [in a new window] |
FIG. 1. Physical maps of the TnYLB-1 delivery plasmids. The TnYLB-1 transposon is contained in an E. coli/B. subtilis shuttle vector carrying a hyperactive allele of the mariner-Himar1 transposase driven from a promoter recognized by A (pMarA; A) or B (pMarB; B) containing RNA polymerase. A control plasmid (pMarC; C) containing the TnYLB-1 transposon but lacking the transposase gene was also constructed. Kanr, kanamycin resistance determinant; ori, pUC19 origin of replication; Ampr, ampicillin resistance determinant; repG+ts, pE194ts origin of replication; Ermr, erythromycin resistance determinant from pE194ts; PA and PB, promoters recognized by A-RNAP or B-RNAP, respectively.
|
B promoter Pctc (15), which had been previously cloned into pUC19 as a 339-bp BamHI/SalI fragment. The EcoRI fragment of pMarC containing the pE194ts replicon and the Ermr cassette, as well as a PstI fragment encoding the Kanr transposon, was then cloned into the Pctc-Himar1 plasmid to form pMarB (Fig. 1). As a result of these amplifications and clonings, two shuttle vectors were constructed that share the ability to replicate in B. subtilis at 30°C but not 50°C and encode Ermr and Kanr (TnYLB-1), which are selectable in B. subtilis. They differ in the promoters that drive the expression of the Himar1 transposase gene. pMarA has Himar1 under the transcriptional control of the B. subtilis housekeeping
factor
A, while pMarB uses the general stress response
factor
B for transposase expression.
mariner transposition in B. subtilis.
The Himar1-expressing plasmids pMarA and pMarB, as well as pMarC, a plasmid containing the Kanr transposable element but not the transposase, were separately transformed into B. subtilis strain PY22 and plated on LB agar containing Kan (5 µg/ml) at 30°C. After 48 h individual colonies were tested as described in Materials and Methods for the presence of intact plasmids and the anticipated phenotypes.
Isolated clones were grown overnight in liquid LB medium at 37°C, and then portions of each culture were plated on either LB, LB plus 5 µg/ml Kan, or LB plus 10 µg/ml erythromycin (Erm) and incubated at the nonpermissive temperature for plasmid replication. Representative data that are the averages of two separate experiments are presented in Fig. 2A. Kanr clones, representing likely transposition events, appeared with approximately equal frequencies (
102) regardless of whether the Himar1 gene was expressed from the PA or Pctc promoter. No antibiotic-resistant clones were detected when B. subtilis carrying the plasmid (pMarC) lacking the transposase coding sequence was plated at 50°C. Approximately 90% of the thermoresistant Kanr clones were sensitive to Erm, the antibiotic resistance encoded by the plasmid but not included within TnYLB-1. Ermr clones could reflect either subpopulations of cells in which plasmid replication had become temperature resistant or transposition events from plasmid multimers in which plasmid sequences, including the Ermr cassette and the transposon, are inserted into the B. subtilis chromosome. In this circumstance, the Himar1 transposase acts on ITR elements of the multimeric plasmids other than those that immediately bracket the Kanr cassette. Transposition of larger plasmid sequences from multimeric plasmids following transpositions of both Tn917 and Tn10 in B. subtilis has been described (39, 22). No Kanr or Ermr clones were found when the Bacillus strain carrying a plasmid without the transposase gene (pMarC) was plated at 50°C (Fig. 2A). This argues that the Ermr clones that we observe are likely a consequence of transposition and not a loss of plasmid temperature sensitivity.
![]() View larger version (50K): [in a new window] |
FIG. 2. TnYLB-1 transposition in B. subtilis. A. CFU resulting from plating of two separate overnight (O/N) cultures of B. subtilis strains carrying either pMarA, -B, or -C at 50°C on LB agar with or without the indicated antibiotics. Transposition frequency is calculated as Kanr colonies/LB colonies. Ermr/Kanr represents the percentage of the O/N cultures that displayed the plasmid-encoded antibiotic resistance (Ermr) versus the transposon-encoded resistance (Kanr). B. Southern hybridization analysis of TnYLB-1 insertions in B. subtilis. Chromosomal DNA from wild-type B. subtilis PY22 (lane 1) or 15 Kanr clones isolated at 50°C from PY22/pMarB (lanes 2 to 16) was digested with EcoRI and analyzed by Southern blotting as described in Materials and Methods, using a hybridization probe specific for TnYLB-1. DNA fragment sizes (kbp) are indicated to the left and are based on DNA markers included in the separating gel. C. Southern blot analysis of the separation of individual TnYLB-1 insertions from a multiple-insertion strain. Chromosomal DNA from a transposant harboring two transposon insertions (lane 1) was extracted and transformed into B. subtilis PY22 to yield transformants with single transposon insertions (lanes 2 and 3).
|
The high frequency of TnYLB-1 transposition and the apparent randomness of its insertion sites on the B. subtilis chromosome argue that it should be a relatively efficient tool with which to isolate insertion mutations. To test this notion, 200 temperature-resistant Kanr clones were spotted onto a glucose minimum medium to screen for auxotrophic mutations and onto DSM to identify clones that had lost the ability to sporulate. Of the 200 clones spotted 2 (Aux1 and -2) failed to grow on the minimal media and 5 separate clones (Spo1 to -5) failed to form Spo+ colonies on DSM. Subsequent transformations with DNA extracted from these clones verified that the phenotypes were the result of the transposon insertions. To identify the B. subtilis genes disrupted by the insertions, as well as to further characterize the insertion sites, chromosomal DNA was extracted from the seven clones with Spo or auxotrophic phenotypes, as well as three additional Kanr clones (M1 to -3) chosen at random. These DNAs were used in an inverse PCR protocol that amplified the chromosomal DNA abutting the transposons ITRs (Materials and Methods). The amplified DNAs were then sequenced and the sequences aligned with the annotated B. subtilis genome (www.genolist.pasteur.fr/SubtiList/) (Table 2). Each of the 10 transpositions that were examined resulted in an insertion at a unique location on the B. subtilis chromosome. Of the five Spo insertions, two lie in characterized sporulation genes (kinA and spoVT) (6, 10). A third insertion lies in a gene (yqfD) whose disruption blocks sporulation and which is part of an operon transcribed by the sporulation-specific sigma factor
E (7, 9). The remaining two Spo insertions are in open reading frames (ybaN and yubB) that have not been studied. The two insertions that led to auxotrophy were found to be in lysA, encoding diaminopimelate decarboxylase, an enzyme in the lysine biosynthetic pathway, and yjzB, a gene of unknown function. Of the three insertions that displayed neither Spo nor auxotrophic phenotypes, two were in open reading frames (ytqI and ybeC) with unknown functions and the third was in the promoter region of the lincomycin resistance operon (lmrBA) (38).
The sequence data also demonstrate that TnYLB-1 had inserted, as expected, at "TA" dinucleotides. To ask whether sequences other than the TA element itself contributed to the insertion at these 10 sites, the nucleotide sequences bordering the TA target were aligned (Fig. 3A) and analyzed for conserved nucleotides using the WebLogo program (www.bio.cam.ac.uk/cgi-bin/seqlogo/logo.cgi) (28). The graphic representation of the sequence conservations at the target sites (Fig. 3B) highlights the invariant TA target element but also suggests a preference for T or A nucleotides 5 bases to either side of the insertion site. Eight of the 10 insertions occurred at TA dinucleotides that had an A or T at both of these positions. All of the insertions had A or T at at least one of them. Aside for this possible A/T preference, there are no additional sequences conserved among the insertion sites.
![]() View larger version (33K): [in a new window] |
FIG. 3. Sequences surrounding the TnYLB-1 insertion sites. A. Sequences surrounding the TA insertion site (boldface) in three random Kanr clones (M1 to M3), five Kanr Spo- clones (Spo1 to -5), and two Kanr auxotrophic clones (Aux1 and -2). The nucleotides at a position 5 bases to either side of the TA are underlined. B. "Web Logo" (http://www.bio.cam.ac.uk/cgi-bin/seqlogo/logo.cgi) consensus analysis of the transposon insertion site sequences (28). Nucleotide sequences at the site of Himar1 insertion are displayed along the horizontal axis. Positions 21 and 22 correspond to the "TA" dinucleotide target. The height and order of each letter in the stack of letters at each position correspond to the relative frequency of the nucleotides at that position. Nucleotides used most frequently are on top. The total height of the stack is an indication of the conservation of a nucleotide at the particular site.
|
B-dependent promoter driving Himar1 transcription would function only in bacterial species with a
B transcription factor (i.e., Bacillus, Listeria, and Staphylococcus spp.) (8), the plasmid (pMarA) with Himar1 expression dependent on a sigma factor (
A) that is common to virtually all bacteria would be expected to have broader application. pMarA, pMarB, and pMarC have been donated to the Bacillus Genetic Stock Center at the Department of Biochemistry, The Ohio State University, 484 West 12th Ave., Columbus, OH 43210 (www.bgsc.org).
Present address: Department of Molecular Virology, Immunology and Medical Genetics, Department of Medicine, Division of Infectious Diseases, and The Centre for Microbial Interface Biology, Ohio State University, Columbus, OH 43210. ![]()
|
|
|---|
E regulon and the identification of additional sporulation genes in Bacillus subtilis. J. Mol. Biol. 327:945-972.[CrossRef][Medline]
E regulon of Bacillus subtilis. Microbiology 149:3023-3034.
B in response to environmental signals. J. Bacteriol. 177:123-133.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»